Jula Inrig Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 13 hours ago
Jula Inrig has an estimated net worth of at least $13.6 million*, as of Oct. 7, 2026. They own 145,165 shares of TVTX stock. They have sold 122,816 shares of TVTX stock since 2021, for an estimated $5.5 million.
Jula Inrig $TVTX SEC Form 4 Insider Trading
Jula Inrig has filed a total of 28 insider trades in $TVTX since 2021. Their most recent trade was a sale of 17,284 shares, made on Sep 15, 2026. Their largest trade was a sale of 25,390 shares, made on Sep 15, 2026. We estimate that they now own 145,165 shares of $TVTX, worth an estimated $8.1 million.
Insider Trading at $TVTX
There have been a total of 261 insider trades reported at $TVTX since 2021, with 0 shares purchased and 2.8 million shares sold. The most active insider traders in $TVTX stock have been Eric M Dube, Christopher R. Cline, and Elizabeth E Reed. The most recent trade was a sale of 47,746 shares reported by WILLIAM E. ROTE (Chief Research Officer), made on Sep 16, 2026.
History of Insider Stock Trades by Jula Inrig
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TVTX
|
Sale | 17,284 | Sep 15, 2026 | Sept. 17, 2026, 9:33 p.m. |
TVTX
|
Sale | 400 | Sep 15, 2026 | Sept. 17, 2026, 9:33 p.m. |
TVTX
|
Sale | 1,600 | Sep 15, 2026 | Sept. 17, 2026, 9:33 p.m. |
TVTX
|
Sale | 25,390 | Sep 15, 2026 | Sept. 17, 2026, 9:33 p.m. |
TVTX
|
Sale | 2,174 | May 05, 2026 | May 6, 2026, 8 p.m. |
TVTX
|
Sale | 311 | May 06, 2026 | May 6, 2026, 8 p.m. |
TVTX
|
Sale | 20,000 | May 04, 2026 | May 6, 2026, 8 p.m. |
TVTX
|
Sale | 1,018 | Apr 15, 2026 | April 15, 2026, 9:46 p.m. |
TVTX
|
Sale | 7,215 | Apr 14, 2026 | April 15, 2026, 9:46 p.m. |
TVTX
|
Sale | 1,547 | Feb 04, 2026 | Feb. 5, 2026, 5:05 p.m. |
TVTX
|
Sale | 232 | Feb 04, 2026 | Feb. 5, 2026, 5:05 p.m. |
TVTX
|
Sale | 6,956 | Feb 03, 2026 | Feb. 3, 2026, 10:30 p.m. |
TVTX
|
Sale | 445 | Jan 06, 2026 | Jan. 7, 2026, 5:05 p.m. |
TVTX
|
Sale | 2,031 | Jan 05, 2026 | Jan. 7, 2026, 5:05 p.m. |
TVTX
|
Sale | 15,000 | Dec 24, 2025 | Dec. 29, 2025, 10:01 p.m. |
TVTX
|
Sale | 815 | Jul 01, 2025 | July 2, 2025, 5:28 p.m. |
TVTX
|
Sale | 2,568 | Feb 12, 2025 | Feb. 12, 2025, 10:22 p.m. |
TVTX
|
Sale | 1,066 | Feb 04, 2025 | Feb. 4, 2025, 9:30 p.m. |
TVTX
|
Sale | 4,207 | Feb 03, 2025 | Feb. 4, 2025, 9:30 p.m. |
TVTX
|
Sale | 440 | Jan 06, 2025 | Jan. 6, 2025, 8:21 p.m. |
TVTX
|
Sale | 2,066 | Jan 03, 2025 | Jan. 6, 2025, 8:21 p.m. |
TVTX
|
Sale | 684 | Sep 10, 2024 | Sept. 10, 2024, 4:05 p.m. |
TVTX
|
Sale | 2,191 | Sep 09, 2024 | Sept. 9, 2024, 9:20 p.m. |
TVTX
|
Sale | 2,174 | Feb 01, 2024 | Feb. 2, 2024, 5:05 p.m. |
TVTX
|
Sale | 440 | Jan 04, 2024 | Jan. 5, 2024, 5:11 p.m. |
TVTX
|
Sale | 2,069 | Jan 03, 2024 | Jan. 5, 2024, 5:11 p.m. |
TVTX
|
Sale | 442 | Jan 05, 2023 | Jan. 6, 2023, 5:05 p.m. |
TVTX
|
Sale | 2,051 | Jan 04, 2023 | Jan. 6, 2023, 5:05 p.m. |
$TVTX Executives and Stock Owners with Insider Trades
-
Eric M Dube, CHIEF EXECUTIVE OFFICER
-
Christopher R. Cline, CHIEF FINANCIAL OFFICER
-
Elizabeth E Reed, Chief Legal Officer and GC
-
Jula Inrig, CHIEF MEDICAL OFFICER
-
Sandra Calvin, SVP, CHIEF ACCOUNTING OFFICER
-
Peter Heerma, CHIEF COMMERCIAL OFFICER
-
Eric M Dube, Chief Executive Officer
-
William E. Rote, Chief Research Officer
-
William E. Rote, Senior Vice President, R&D
-
Elizabeth E Reed, SVP, GC & Corporate Secretary
-
Sandra Calvin, SVP, Chief Accounting Officer
-
Peter Heerma, Chief Commercial Officer
-
Peter Heerma, EVP, CHIEF COMMERCIAL OFFICER
-
Elizabeth E Reed, SVP, GC & CORPORATE SECRETARY
-
William E. Rote, SENIOR VICE PRESIDENT, R&D
-
Laura Clague, Chief Financial Officer
-
Christopher R. Cline, Chief Financial Officer
-
Jula Inrig, EVP, Head of R&D & CMO
-
Jula Inrig, Chief Medical Officer
-
Noah L. Rosenberg, Chief Medical Officer
-
Sandra Calvin, VP, Corp Controller and CAO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.